➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts
McKinsey
Moodys
AstraZeneca

Last Updated: January 18, 2021

DrugPatentWatch Database Preview

Litigation Details for University of Utah Research Foundation v. Quest Diagnostics (D. Utah 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

University of Utah Research Foundation v. Quest Diagnostics (D. Utah 2013)

Docket   Start Trial Date Filed 2013-10-22
Court District Court, D. Utah Date Terminated 2015-02-10
Cause 35:0271 Patent Infringement Assigned To Robert James Shelby
Jury Demand Plaintiff Referred To
Parties ENDORECHERCHE; HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP; MDL PANEL; MYRIAD GENETICS; QUEST DIAGNOSTICS; QUEST DIAGNOSTICS NICHOLS INSTITUTE; TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA; UNIVERSITY OF UTAH RESEARCH FOUNDATION
Patents 6,051,379; 6,083,698
Attorneys Benjamin G. Jackson; Brook B. Bond; C. Kevin Speirs; David G. Mangum; Elizabeth M. Flanagan; Emmett J. McMahon; Geoff D. Biegler; Jamie R. Kurtz; Jared J. Braithwaite; Jonathan E. Singer; Kristine A. Tietz; Kristine E. Johnson; Larry R. Laycock; Martin R. Lueck; Matthew B. McFarlane; Matthew S. Gordon; MDL Panel; Michael R. McCarthy; Tara S.G. Sharp
Firms Emmett J. McMahon; Fish & Richardson - San Diego; Fish & Richardson Pc; Kristine A. Tietz; Martin R. Lueck; Maschoff Brennan Pllc; Myriad Genetics Inc; Parsons Behle & Latimer; Robins Kaplan LLP; Robins Kaplan Miller & Ciresi LLP
Link to Docket External link to docket
Biologic Drugs cited in University of Utah Research Foundation v. Quest Diagnostics
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for University of Utah Research Foundation v. Quest Diagnostics (D. Utah 2013)

Date Filed Document No. Description Snippet Link To Document
2013-10-31 14 . 6,051,379, # 7 Exhibit 7 - U.S. Patent No. 6,951,721, # 8 Exhibit 8 - U.S. Patent No. 7,250,497, # 9…inclusive. 58. United States Patent No. 6,051,379 (the “’379 Patent”) was duly and legally issued by…84108. Myriad owns United States Patent Nos. 5,654,155; 5,750,400; 6,051,379; 6,951,721; 7,250,497; 6,083,698…United States Patent Nos. 5,709,999; 5,747,282; 5,753,441; 5,837,492; 6,033,857; 6,051,379; 6,951,721; …Myriad for Infringement of United States Patent No. 6,051,379) 57. Plaintiff Myriad repeats External link to document
2013-10-23 3 States Patent No. 6,033,857 (Parts 1, 2, and 3) 6. United States Patent No. 6,051,379 …United States Patent No. 5,709,999 (Parts 1, 2, and 3) 2. United States Patent No. 5,747,282…United States Patent No. 5,753,441 (Parts 1, 2, and 3) 4. United States Patent No. 5,837,492…. United States Patent No. 6,951,721 (Parts 1 and 2) 8. United States Patent No. 7,250,497 … 10 February 2015 2:13-cv-00967 830 Patent Plaintiff District Court, D. External link to document
2013-10-23 4 Partnership, Trustees of the Univ. of Pennsylvania 6 6,051,379 Apr. 18, 2000 Oncormed… Trademarks or W Patents ( the patent action involves 35 U.S.C. § 292.): …Partnership, Myriad Genetics PATENT OR DATE OF PATENT OR … Bill Other Pleading PATENT OR DATE OF PATENT OR …Filing of an action sent to the Director of the U.S. Patent and Trademark Office. (rls) (Entered: 10/23/2013 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Express Scripts
Baxter
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.